Is Gulf Keystone Petroleum Limited Or Sirius Minerals PLC Today’s Top Resource Play?

Could Sirius Minerals PLC (LON:SXX) outperform Gulf Keystone Petroleum Limited (LON:GKP) over the next year?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in potash miner Sirius Minerals (LSE: SXX) climbed 7% to 14p on Thursday, after the firm gained the first of two planning approvals needed to develop its potash mine in the North York Moors National Park.

The firm’s shares have now risen by 45% over the last year, despite having hit a 52-week low of 6.4p in January.

In contrast, Kurdistan oil producer Gulf Keystone Petroleum (LSE: GKP) has pumped increasing amounts of oil out of its prize Shaikan asset over the last year, but the firm’s shares have fallen by 55%.

Both companies look cheap compared to the potential value of their main asset, mainly because both are running out of cash, leaving shareholders in an uncertain position.

Sirius 3, Gulf Keystone 0

On the face of it, Sirius has three key advantages over Gulf Keystone in terms of fundraising.

Firstly, Sirius operates in a stable political environment, where companies do not face the risk of disruption or loss, as a result of conflict or regime change.

Secondly, Sirius doesn’t have any existing debt to speak of, whereas Gulf Keystone already has more than $500m of quite costly debt, and requires further investment to maximise production from Shaikan.

Finally, unlike Gulf Keystone, Sirius, it doesn’t have $100m of bad debt owed by its main customer, the Kurdistan government, which has so far refused to pay for much of the oil Gulf has exported.

It’s not that simple

On the other hand, Gulf Keystone does have some advantages of its own.

Gulf has fully-functioning production facilities pumping nearly 40,000 barrels of oil per day straight into export markets.

Demand for Kurdish oil is proven, and there is growing confidence among all operators in the region that the Kurdish authorities will establish a regular payment cycle this year.

What’s more, oil prices now seem to have bottomed out.

In contrast, Sirius only owns the rights to a large mineral deposit in the ground.

Several years of construction and an estimated $2.5bn of investment is expected to be required before the firm can hope to receive any revenue, with first production targeted for 2018.

The size and value of the fertiliser market Sirius is targeting are also less well understood.

I’d say evens

Interestingly, the US investment giant Capital Group recently increased its stake in Gulf Keystone from 5% to 7%, suggesting it believes there is upside for shareholders.

However, I think it’s too close to call: I suspect both companies will deliver a rollercoaster ride over the coming months.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »

Investing Articles

Here’s how investors could aim for a £6,531 annual passive income from £11,000 of Aviva shares

As a stock’s yield rises when its price falls, I'm not bothered by Aviva shares’ apparent inability to break the…

Read more »